Global Advanced Research Journal of Medicine and Medical Sciences (GARJMMS) ISSN: 2315-5159
July 2017 Vol. 6(7), pp. 156-161
Copyright © 2017 Global Advanced Research Journals
Full Length Research Paper
Heterogeneity of GST enzymatic activity before and after treatment in patients with breast cancer: pilot study
Fernando Mejia Sanchez1, Marisol Rodríguez Albarrán2, J. Amado López Arriaga1 and Julieta Castillo Cadena1*
1Centro de Investigación en Ciencias Médicas, Universidad Autónoma del Estado de México, Jesús Carranza No. 205, Col. Universidad, Toluca de Lerdo, México. C.P. 50130.
2Facultad de Química, Universidad Autónoma del Estado de México. Paseo Colón esq Paseo Tollocan S/N. Toluca de Lerdo, México. C.P. 50100.
*Corresponding Author E-mail: firstname.lastname@example.org
Accepted 12 July, 2017
Exposure to anticancer agents such as cyclophosphamide and adriamycin promote the expression and synthesis of gene products whose function is cell protection, such as the family of isoenzymes of glutathione S-transferase, involved in Phase II detoxification of xenobiotics by glutathione conjugation. Response to the treatment is uncertain and different for each patient. Our objective was to determine total GST and GSTT1 enzyme activity induced by the treatment in women with breast cancer and the variability of the response. In 22 women with breast cancer, the total GST and GSTT1 enzymatic activity before and after treatment. The magnitude of enzymatic activity was different in each patient before and after treatment. The value of the median of total GST enzyme activity before treatment was 2.425 μmol/min/mL and after 3.253 μmol/min/mL, it was significantly different, p<0.05. For GSTT1 the median values of enzymatic activity before and after treatment were 0.015 and 0.021 μmol/min/mL, respectively, it was significantly different, p<0.05. Adriamycin and cyclophosphamide induce the expression of GST isoenzymes by increasing the enzymatic activity after treatment. The heterogeneity of enzymatic activity as a treatment response shall be considered for its prescription.
Keywords: Total GST enzyme activity, GSTT1 enzyme activity, breast cancer, adriamycin, cyclophosphamide
Alvarado MA, Arrieta O, Gamboa VC, Saavedra PD, Morales BR, Bargallo RE, Lara MF (2009). Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer. Radiat. Oncol. 4: 24.
Avril N, Sassen S, Roylance R (2009). Response to therapy in breast cancer. J. Nucl. Med. 50:55-63.
Avril S, Muzic RF, Plecha D, Traughber BJ, Vinayak S, Avril N (2016). ¹⁸F-FDG PET/CT for monitoring of treatment response in breast cancer. J. Nucl. Med. 57: 34S-39S.
Castillo JC, Contreras GS, Poblano BR, Posadas GR, Ramírez GJ (2007). Actividad en la enzima Glutatión S-transferasa T1 en floricultores expuestos a plaguicidas. Bioquímia. 32: 138.
Cheng X, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Okada M,Terakawa N (1997). Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy. Cancer. 79: 521-527.
Davies SM, Robison LL, Buckley JD, Tjoa T, Woods WG, Radloff GA, Perentesis JP (2001). Glutation S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J. Clin. Oncol. 19: 1279-1287.
Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR (1986). Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res. 46: 2578-81.
Garibay GJ, Mejia SF, Ramírez SJE, Flores MMV, Castillo CJ (2015). Genotoxic and cytotoxic damage by cyclophosphamide and adriamycin as a response to treatment in breast cancer patients: Pilot study. J. Cancer. Ther. 6: 163-168.
Geng M, Wang L, Chen X, Cao R, Li P (2013). The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer. Diagn. Pathol. 10: 198.
Guo X, Zeng Y, Deng H, Liao J, Zheng Y, Li J, O'Brien SJ (2010). Genetic polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the risk of naso-pharyngeal carcinoma in a chinese population of southern China. BMC Res. Notes. 27: 212-321.
Habig WH, Pabst MJ, Jakoby WB (1974). Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7139.
Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Ann. Rev. Pharmacol. Toxicol. 45: 51-88.
http://dof.gob.mx/nota_detalle.php?codigo=5284148&fecha=04/01/2013. Accessed 22 May 2017.
Jankova L, Robertson G, Chan C, Tan KL, Kohonen-Corish M, Fung CL, Clarke C, Lin BP, Molloy M, Chapuis PH, Bokey L, Dent OF, Clarke SJ (2012). Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study. BMC Cancer. 28: 1-9.
Kiran B, Karkucak M, Ozan H, Yakut T, Ozerkan K, Sag S, Ture M (2010). GST (GSTM1, GSTT1 and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J. Gynecol. Oncol. 21: 169-173.
Knaul FM, Nigenda G, Lozano R, Arreola OH, Langer MD, Frenk J (2009). Cáncer de mama en México: una prioridad apremiante.Salud Pública Méx. 51: 335-230.
Mejia F, Cadena CJ, Sánchez MJC (2013). Development and application in Mexican of a method for the Identification of polymorphisms of GSTP1. J. Med. Med. Sci. 4: 287-290.
Meza JJ, Montaño LA, Aguayo GA (2006). Bases moleculares del cáncer. Rev. Invest. Clin. 58: 56-70.
Murphy D, McGown AT, Hall A, Cattan A, Crowther D, Fox BW (1992). Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before or after cytotoxic chemotherapy. Br J. Cancer. 66: 937–942.
Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB (1994). Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J. 300: 271-276.
Rodríguez M, Mejia F, Lecourtois M, Domínguez V, Castillo J (2014). Influence of GSTT1, GSTM1 and GSTP1 polymorphisms on the development of breast cancer. J. Cancer Ther. 5: 552-559.
Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, Morandi P, Fan C, Rabiul I, Ross JS, Hortobagyi GN, Pusztai L (2005). Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11: 5678-5685.
Ruvalcaba LE, Robles VC, Poitevin CA, Chávez MM, Gamboa VC, Vilar CD (2006). Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis. Breast Cancer Res. Treat. 95: 147-152.
Ruvalcaba LE, Barreda ZLE, García ON, Morales VF, Bautista PV, Maffuz AA, Rodríguez CS (2014). Respuesta a la quimioterapia neoadyuvante (QTneo) según los subtipos intrínsecos determinados por inmunohistoquímica (IHQ) en pacientes con cáncer de mama. Gac. Med. Mex. 150: 161-170.
Schecter RL, Woo A, Duong M, Batist G (1991). In vivo and in vitro mechanisms of drug resistance in a rat mammary carcinoma model.Cancer Res. 51:1434-42.
Soto O, Cabrera GP, Téllez TG, Barrera FJL, Juárez RA, Castillo CJ (2011). Relationship of polymorphisms of Glutathione S-Transferase GSTT1 and GSTM1 with the response to chemotherapy in Mexican women with advanced breast cancer. J. Cancer Ther. 2: 354-361.
Uzilov AV, Ding W, Fink MY, Antipin Y, Brohl AS, Davis C, Lau CY, Pandya C, Shah H, Kasai Y, Powell J, Micchelli M, Castellanos R, Zhang Z, Linderman M, Kinoshita Y, Zweig M, Raustad K, Cheung K, Castillo D, Wooten M, Bourzgui I, Newman LC, Deikus G, Mathew B, Zhu J, Glicksberg BS, Moe AS, Liao J, Edelmann L, Dudley JT, Maki RG, Kasarskis A, Holcombe RF, Mahajan M, Hao K, Reva B, Longtine J, Starcevic D, Sebra R, Donovan MJ, Li S, Schadt EE, Chen R (2016). Development and clinical application of an integrative genomic approach to personalized cancer therapy. Genome Med. 8: 62.
Zhong SL, Zhou SF, Chen X, Chan SY, Chan E, Ng KY, Huang M (2006). Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese. Eur. J. Pharm. Sci. 28: 77-85.
- Fern on Google Scholar
- Fern on Pubmed
- o Mejia Sanchez on Google Scholar
- o Mejia Sanchez on Pubmed
- Marisol Rodríguez Albarrán on Google Scholar
- Marisol Rodríguez Albarrán on Pubmed
- J. Amado López Arriaga on Google Scholar
- J. Amado López Arriaga on Pubmed
- Julieta Castillo Cadena on Google Scholar
- Julieta Castillo Cadena on Pubmed